Category Archives: Uke 36

This weeks edithorial


As the newly appointed research leader at K2, this is my first editorial in K2-nytt. I am a medical specialist in infectious diseases and completed a PhD in 2012 on clinical and immunological analyses of patients with long-term complaints following the Giardia outbreak in 2004. Since then, I have researched diarrheal diseases and immunology with Giardia, ETEC, and Cryptosporidium as my favorite microbes.

In my new role, there is much I want to familiarize myself with. I have started by getting an overview of the research activities at K2. Measured in publications, K2 is involved in around 480 scientific articles per year. This has been stable over the past four years. 65% of our publications have international co-authorship, and 89% are published with open access. It is gratifying that the proportion of high-quality publications, published in the more selective level-2 journals, has shown positive development from 18% in 2021 to 25% in 2023. Our research publication relative to our number of first positions and full-time equivalents has remained stable in recent years.

The goal must be to maintain or improve the quality and research production at K2 despite tight finances and necessary cost-saving measures that must be implemented this year and next year. We managed to keep going through the pandemic, and I see it as an important task for me in my role as research leader at K2 to help ensure that we achieve this in the future as well.

I have an office on the 5th floor of the Lab building if you want to have a chat with me. For those interested in more publication statistics from UiB, this can be found at https://bibliometri.w.uib.no/

Hilde Eide Lien – Public defence September 3th.

The candidate is from the Department of Clinical Science Main supervisor: Professor Camilla Krakstad Co-supervisors: Professor Lars Andreas Akslen and Professor Ingfrid Salvesen Haldorsen

Trial lecture: Friday, September 13, 2024, at 09:15
Location: Auditorium, Glasblokkene, Haukelandsbakken 15 Assigned topic: “Immune tumour microenvironment composition in endometrial cancer and its relationship with therapy response”

Defense: Friday, September 13, 2024, at 11:15
Location: Auditorium, Glasblokkene, Haukelandsbakken 15 Thesis title: “Single cell expression patterns in endometrial cancer and novel biomarkers for improved treatment”

1st opponent: PhD Laura Muinelo Romay, University of Santiago de Compostela, Spain

2nd opponent: PhD Hanne Askautrud, Oslo University Hospital

3rd committee member: PhD André Sulen, University of Bergen

The defense will be chaired by Professor Emerita Birgitta Åsjø.

Open to all interested parties

Incentive funds for teaching

UiB has awarded NOK 2,150,000 as incentive funds for teaching-related innovation, distributed across 14 projects. Two grants went to environments associated with K2: Silje Skrede, Jon Andsnes Berg, and Trond Trætteberg Serkland were awarded NOK 150,000 for the project ‘Transition to digital, student-focused teaching in basic pharmacology for medical students’ (https://streamable.com/49djn7). Reidun L. S. Kjome at the Center for Pharmacy was awarded NOK 130,000 for the project ‘Global competence through virtual exchange.’

 

Ethics and integrity for AI in research

How can we promote the ethical use of AI? How might AI be employed to advance fundamental values and committments in science-related research and communication? And how can research practices in this new digital environment be assessed? These are the questions that this webinar will address.

Artificial intelligence (AI) is disrupting and revolutionising science by accelerating research progress, boosting innovation, and improving researchers’ productivity. The European Union (EU) has embraced the opportunities this brings, including AI’s potential to make science more accessible, reduce inequities, and contribute to mitigating the reproducibility crisis. At the same time, we must be ready to respond to the challenges and threats associated with this fast-evolving technology, such as the risks of furthering inequalities, exacerbating biases, and developing unethical behaviours among scientists and academics as well as by their institutions.

10 September 2024 14:00-15:30

https://scientificadvice.eu/events/ethics-and-integrity-for-ai-in-research/

The Aurora Mobility Programme – Researcher Exchange for New Collaboration Between Norway and France

The support provided through the AURORA mobility programme should contribute to establishing and expanding contact between research organisations in Norway and corresponding organisations in France. The purpose is to strengthen European research collaboration under Horizon Europe.
Researchers from Norway may seek funding for short-term visits in France for the purpose of launching and developing new joint research projects.

https://www.forskningsradet.no/en/call-for-proposals/2024/the-aurora-mobility-programme–researcher-exchange-for-new-collaboration-between-norway-and-france/

 

 

Save the date – Microplastic and Human Health Symposium

The Plastic Network at UiB and collaborators will also this autumn organize a one-day symposium on microplastics, this time concerning Microplastics and Human Health.

During this meeting, we will focus on the multifaceted issues surrounding microplastic pollution, human exposure, and its impact on human health.

Title: Microplastics and Human Health; sources, exposure, and impact
Date: November 22nd , 2024
Location: Department of Biological Sciences, University of Bergen
Virtual access: Online attendance on Zoom is possible
Speakers: We have invited renowned experts and early career scientists in the field of microplastic research. Confirmed speakers so far include Dorthe Herzke (FHI), Asbjørn Jokstad (UiT), Øyvind Pernell Haugen (STAMI), and Damaris Daniel (UiB). Updated and detailed scientific program will be published online in due time.

Who should attend: This symposium is designed for researchers, healthcare professionals, environmental scientists, policy makers, and anyone interested in understanding the growing concern over microplastics and their implications for human health.

More information about the meeting including full scientific program and registration will be provided soon.

Warm regards,
Organizing committee: Amy Lusher (NIVA), Tanja Kögel (HI), Jutta Dierkes (UiB) and Odd André Karlsen (UiB)

 

 

Looking for partners and joining consortia

  1. sep. kl. 09.00–11.00

The webinar will answer and discuss with the participants the following questions and issues:

  • How to find the key actors in a specific field? Which websites or portals to check if you want to find information on Horizon Europe, scientific achievements or key results? How can you join a consortium that is preparing a proposal?
  • How can you make yourself more visible for European researchers and key organisations?

The course language is English, and the course is delivered by Europa Media.

https://www.forskningsradet.no/arrangementer/2024/heu-kurs-host-2024/A2-looking-for-partners-and-joining-consortia-short-webinar/

Newsletter – International HR – September 2024

Please find our newsletter online by clicking on the image above or follow this link: NEWSLETTER SEPTEMBER 2024.

You can also find our previous newsletters in this link.

Wishing you all a wonderful day and please do not hesitate to contact us for any questions or queries you might have.

All the best from the Euraxess team at the International Centre.

TMex course – “Translational Medicine Explained”

Barcelona, 22-25 October.

This four-day course offers a unique opportunity to delve into the complexities of translating biomedical discoveries into solutions for unmet medical needs. It explores the importance of a truly interdisciplinary approach, where collaboration across various disciplines is not just encouraged but essential.

https://eatris.eu/events/translational-medicine-explained-tmex-2024/

 

 

Nordic Cancer Conference

Monday October 7th in Stockholm

Bonnier Healthcare, together with Nordic Cancer Union’s members, invites you to the Nordic Cancer Conference. The venue will take place in Stockholm, Bonnier Huset, Torsgatan 21. It is also possible to participate by streaming.

The program is under construction and will be updated. It is designed together with a reference group consisting of:
Norwegian Cancer Society, Ole Alexander Opdalshei – Deputy Secretary General
The Swedish Cancer Society, Ulrica Sundholm, Manager Knowledge & Support
The Danish Cancer Society: Heidi Smollerup Rasmussen, Chief Consultant policy and legal
Bonnier Healthcare Norway, Martin Gray – Editor in Chief Dagens Medisin, and moderator for the conference.

We are delighted to welcome you to our conference where leading experts, researchers, and policymakers from across the Nordic countries come together to address one of the most pressing health challenges of our time: cancer. We will focus on four key areas:  prevention, cancer strategy, access to new medicines, clinical trials.

https://www.dagensmedisin.no/dmarena/nordic-cancer-conference/641490